A Randomized Trial of Internet Access to Nicotine Patches (iQS)

January 21, 2015 updated by: Lawrence C. An, University of Michigan

iQuit Smoking: A Randomized Trial of Internet Access to Nicotine Patches

People who smoke cigarettes have an increased risk of developing emphysema, heart disease, and certain types of cancer. This study will evaluate the effectiveness of providing free nicotine patches from an online smoking cessation program, with and without telephone counseling, at improving quit rates in cigarette smokers.

Study Overview

Detailed Description

The objective of this project is to determine the efficacy and cost-effectiveness of providing access to free nicotine patches, with or without a required linkage to proactive telephone counseling, as adjuncts to internet-assisted tobacco treatment. Online cessation services will be provided by the Center for Health Communication Research at the University of Michigan.

This investigation has three specific aims and one exploratory aim:

  • Specific Aim 1: To determine the efficacy of providing access to free nicotine patches as an addition to online smoking cessation services.
  • Specific Aim 2: To determine the efficacy of providing access to free nicotine patches linked with proactive telephone counseling as an addition to online smoking cessation services.
  • Specific Aim 3: To determine the cost-effectiveness of providing access to free nicotine patches, with or without linkage to proactive phone counseling, as additions to online cessation services.
  • Exploratory Aim 1: To examine potential mediators and moderators of intervention effects. An examination of potential mediators will identify key psychological and behavioral processes (e.g. medication adherence, self-efficacy, etc.) that underlie how the interventions affect the process of quitting and offer guidance regarding key targets for future research. An examination of potential moderators (e.g. level of dependence, income, gender) will identify candidate subgroups for which the proposed interventions may be more effective and cost- effective.

Smokers searching online for help quitting (N=2,475) will be recruited and randomized to receive one of three treatments:

  1. online smoking cessation services (i.e. web),
  2. online cessation services plus access to free nicotine patches (i.e.web+patch),
  3. online cessation services with access to free patches contingent upon participation in proactive telephone counseling (i.e. web+patch+phone).

The Center for Health Communications Research at the University of Michigan will serve as the smoking cessation website for this research project. Developed by Vic Strecher and colleagues, Project Quit is a web-based program designed to help individuals who would like to quit smoking in the next 30 days. The program is grounded in cognitive-behavioral methods of smoking cessation and relapse prevention. The web-based smoking cessation intervention features highly tailored email messages. Once enrolled in the project and the baseline assessment is completed, participants receive six tailored web sessions namely:

  • Action plan (1 week before quit date);
  • Barriers 1 (2 days before quit date);
  • Supportive message (on quit date);
  • Barriers 2 (2 days after quit date);
  • Motivation (1 week after quit date);
  • Testimonial (2 weeks after quit date).

Evaluations will occur at baseline and at 1-, 3-, and 9-months post-enrollment. The primary outcome measure will be self-reported 6-month prolonged abstinence measured at the 9-month evaluation.

This proposal addresses a critical need for evidence-based cessation treatments for smokers. At the completion of this project, it is our expectation that we will have identified an effective online intervention package (or packages) for dissemination of internet-assisted tobacco treatment.

This study will enroll people recruited via online sources. Participants will complete a baseline survey about their smoking habits and quit history. Participants will then be randomly assigned to one of the following three treatment groups:

  • Group 1 participants will receive access to an online tailored stop smoking program.
  • Group 2 participants will receive free access to nicotine patches and an online tailored stop smoking program.
  • Group 3 participants will receive telephone counseling, free access to nicotine patches and an online tailored stop smoking program.

Participants receiving telephone counseling will receive 5 phone calls over a 2-month period to discuss their personal smoking cessation plan; they must complete the pre-quit and 7-10 day calls in order to receive the nicotine patches. At 1, 3, and 9 months post-enrollment, all participants will complete online surveys about their smoking cessation experience. Participants will be contacted by phone to complete the surveys if they do not complete them online.

Study Type

Interventional

Enrollment (Actual)

2485

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Michigan
      • Ann Arbor, Michigan, United States, 48109
        • University of Michigan

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Currently smokes 10 or more cigarettes per day
  • Does not use any tobacco products other than cigarettes
  • Willing to set a quit date within 2 to 4 weeks following study entry
  • Willing to use a nicotine patch
  • Able to speak English
  • Access to Internet, email, and telephone at work or home
  • Resident of the United States
  • Only one person per household is eligible to enroll

Exclusion Criteria:

  • Medically unable to use the nicotine patch (e.g., pregnant, history of a heart attack)
  • Currently uses nicotine replacement therapy (NRT) products
  • Currently uses or plans to use Bupropion SR, Wellbutrin, or Zyban

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: NRT Patch, Phone Counseling, Internet
As adjuncts to internet-assisted tobacco treatment (iQuit Smoking website), research participants in this arm will have access to free 8-week supply of nicotine patches, contingent upon participation in proactive telephone counseling. Patch therapy will begin with the 21 mg patch for 4 weeks, followed by 14 mg patch for 2 weeks, then 7 mg patch for 2 weeks.
Participants will wear nicotine patches.
Other Names:
  • Nicoderm CQ
Participants receiving telephone counseling will receive five phone calls over a 2-month period to discuss their personal smoking cessation plan.
Participants will access the Project Quit (iQuit Smoking) website.
Active Comparator: Nicotine Patches and Internet
As adjuncts to internet-assisted tobacco treatment (iQuit Smoking website), research participants in this arm will have access to free 8-week supply of nicotine patches. Patch therapy will begin with the 21 mg patch for 4 weeks, followed by 14 mg patch for 2 weeks, then 7 mg patch for 2 weeks.
Participants will wear nicotine patches.
Other Names:
  • Nicoderm CQ
Participants will access the Project Quit (iQuit Smoking) website.
Placebo Comparator: Internet
Research participants in this arm will have free access to internet-assisted tobacco treatment (iQuit Smoking website).
Participants will access the Project Quit (iQuit Smoking) website.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Self-reported 6-month Prolonged Abstinence From Smoking
Time Frame: Measured at 9 Months post-randomization
Participants complete the final study survey 9 months following enrollment in the program. They are asked to report when they had last smoked a cigarette, even a puff. Participants who report that they have not smoked in the past 6 months are counted as abstinent for the purposes of our study analysis.
Measured at 9 Months post-randomization

Secondary Outcome Measures

Outcome Measure
Time Frame
Self-reported 30-day Prolonged Abstinence at 9-month Follow up
Time Frame: 9 months post randomization
9 months post randomization
Self-reported 30-day Prolonged Abstinence at 3-month Follow up
Time Frame: 3-months post randomization
3-months post randomization

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Lawrence C An, MD, University of Michigan

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2011

Primary Completion (Actual)

March 1, 2014

Study Completion (Actual)

March 1, 2014

Study Registration Dates

First Submitted

September 21, 2007

First Submitted That Met QC Criteria

September 21, 2007

First Posted (Estimate)

September 24, 2007

Study Record Updates

Last Update Posted (Estimate)

February 3, 2015

Last Update Submitted That Met QC Criteria

January 21, 2015

Last Verified

January 1, 2015

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Smoking Cessation

Clinical Trials on Nicotine patches

3
Subscribe